Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
Le Zhang(Karolinska Institutet), Liangjing Lu(Shanghai Jiao Tong University), Shuang Ye(Little Swan (China)), Dandan Chen(Shanghai Jiao Tong University), Shaoying Yang(Shanghai Jiao Tong University), Jie Chen(Huazhong Agricultural University), Jun Li(Shanghai Jiao Tong University), Yuan Li(Fuyang City People's Hospital), Ting Li(Union Hospital), Zhiwei Chen(Shanghai Jiao Tong University), Liyang Gu(Shanghai Jiao Tong University), Yakai Fu(Inserm), Hanlin Yin(Shanghai Jiao Tong University)
Cited by 26
Related Papers
Autophagy Enhancer Carbamazepine Alleviates Memory Deficits and Cerebral Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease
|Current Alzheimer Research|2013|148
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
|JAMA Psychiatry|2023|128
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
|Nature Communications|2022|112
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
|Patient Preference and Adherence|2018|111
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2019|95